Berger, A K. (22 March 2012). A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: The Heidelberg REMOTUX trial. BMC cancer, 12, . doi:10.1186/1471-2407-12-108

"A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer : The Heidelberg REMOTUX trial / Anne Katrin Berger, Carl von Gall, Ulrich Abel, Stefan Delorme, Matthias Kloor, Jennifer Ose, Tim Frederik Weber, Annika Stange, Georg Martin Haag, Uwe Haberkorn, Florian Lordick, Dirk Jäger" BMC Cancer .

Berger, Anne Katrin. "A Phase II Study for Metabolic in Vivo Response Monitoring With Sequential 18FDG-PET-CT During Treatment With the EGFR-monoclonal-antibody Cetuximab in Metastatic Colorectal Cancer: The Heidelberg REMOTUX Trial." BMC Cancer 12 (22 March 2012).